MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Single-cell characterization of patient midbrain tissue reveals tissue remodeling and glial activation in Parkinson’s disease

    S. Smajic, C. Prada-Medina, Z. Landoulsi, J. Ghelfi, S. Delcambre, C. Dietrich, J. Jarazo, J. Henck, S. Balachandran, S. Pachchek, C. Morris, P. Anotny, B. Timmermann, S. Sauer, S. Pereira, J. Schwamborn, P. May, M. Spielmann (Esch-sur-Alzette, Luxembourg)

    Objective: We aim to characterize the contribution of each midbrain cell type to PD pathology, and to identify cell types associated with genetic PD-risk variants.…
  • 2022 International Congress

    Sleep stability, arousals and cycle structure in alfa-synucleinopathies: a comparative study between isolated REM sleep behaviour disorder (iRBD), Parkinson’s Disease (PD) and Dementia with Lewy Bodies (DLB)

    M. Magriço, P. Bugalho (Lisboa, Portugal)

    Objective: To compare sleep stability, arousals and sleep cycle structure between two sets of diagnosis: iRBD vs PD vs DLB; patients with RBD (RBD+) vs…
  • 2022 International Congress

    Quality of life changes after subthalamic stimulation for Parkinson’s disease depend on nonmotor and motor symptoms clusters

    L. Braun, S. Jost, M. Silverdale, A. Rizos, M. Santos Ghilardi, R. Cury, P. Loehrer, C. Nimsky, K. Ashkan, A. Sauerbier, A. Gronostay, G. Fink, M. Barbe, J. Evans, V. Visser-Vandewalle, E. Fonoff, A. Antonini, L. Timmermann, P. Martinez-Martin, K. Chaudhuri, H. Dafsari (Cologne, Germany)

    Objective: To analyze quality of life (QoL) changes after subthalamic stimulation (STN-DBS) based on a short list of baseline nonmotor and motor symptoms in Parkinson’s…
  • 2022 International Congress

    Emotion Recognition and Risk-Taking Behaviour in Early Parkinson’s Disease

    A. Slomp, D. de Waard, S. Vander Zee, S. Slingerland, J. Boertien, J. Spikman, T. van Laar, R. Huitema (Groningen, Netherlands)

    Objective: To assess the association between facial emotion recognition and traffic-related risk-taking behaviour in early Parkinson’s Disease (PD) patients. Background: Risk-taking behaviour is an important…
  • 2022 International Congress

    Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

    C. Gonzalez-Robles, M. Bartlett, M. Burnell, R. Chapman, R. Chaudhuri, C. Clarke, R. Ellis-Doyle, M. Hu, B. Huxford, A. Jha, M. Lawton, G. Mills, A. Noyce, P. Piccini, L. Rochester, J. Rudiger, C. Siu, D. van Wamelen, C. Williams-Gray, ML. Zeissler, H. Zetterberg, C. Carroll, T. Foltynie, R. Weil, A. Schrag (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatment for…
  • 2022 International Congress

    Predictors of short-term anxiety outcome after subthalamic stimulation in Parkinson’s Disease

    A. Sauerbier, V. Stopic, J. Herberg, P. Loehrer, K. Ashkan, A. Rizos, S. Jost, JN. Petry-Schmelzer, S. Heil, A. Gronostay, M. Barbe, V. Visser-Vandewalle, J. Evans, C. Nimsky, G. Fink, A. Antonini, P. Martinez-Martin, M. Silverdale, D. Weintraub, A. Schrag, K. Ray Chaudhuri, L. Timmermann, H. Dafsari (Cologne, Germany)

    Objective: To identify clinical predictors of the effect of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s Disease (PD). Background: STN-DBS is a…
  • 2022 International Congress

    Assessment of cognitive functions and gait in PD and ET patients with pharmacoresistant tremor treated with Gamma Knife thalamotomy.

    M. Figura, L. Milanowski, K. Sadowski, A. Korn, A. Ziobro, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our study was to assess the impact of unilateral Gamma Knife thalamotomy on gait and balance and well as psychological functioning…
  • 2022 International Congress

    BBP-671, AN INVESTIGATIONAL MODULATOR OF PANTOTHENATE KINASES, DEMONSTRATES PROOF OF CONCEPT IN A PKAN MOUSE MODEL AND TARGET ENGAGEMENT IN HUMANS

    D. Gretler, A. Jurecka, R. Sukhun, C. Henry, A. Wade, M. Harden, C. Subramanian, M. Frank, R. Lee, C. Rock, S. Jackowski, S. Rao, U. Sinha (San Francisco, USA)

    Objective: Efficacy of BBP-671 as a potential therapy for pantothenate kinase-associated neurodegeneration (PKAN) was evaluated in a PKAN mouse model. Safety, PK, and PD of…
  • 2022 International Congress

    Targeted training improves touchscreen skills in Parkinson’s disease and healthy elderly

    J. de Vleeschhauwer, E. Nackaerts, B. Vandendoorent, Y. Zhang, L. Janssens, A. Nieuwboer (Leuven, Belgium)

    Objective: To investigate the effects of dual (DT) versus single task (ST) training of touchscreen skills in Parkinson’s disease patients (PD) and healthy elderly (HE).…
  • 2022 International Congress

    Huntington’s Disease, Cognition, and Fear of Falling

    A. Sethi, S. Baek, O. Kaczmarek, B. Bumstead, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship of cognition and patient-reported assessment on fear of falling in people with Huntington’s Disease. Background: Huntington’s Disease (HD) is a relentlessly…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley